Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PMN | NASDAQ | USD | Real-time | |
23J0 | Frankfurt | EUR | Delayed |
For the three months ended 31 March 2022, Promis Neurosciences Inc revenues increased from C$0K to C$14K. Net loss decreased 59% to C$3.1M. Revenues reflect Interest earned increase from C$0K to C$8K, Sales and royalty income increase from C$0K to C$5K. Lower net loss reflects FV/Uls Adjust on Derivatives for Hedging increase from C$7M (expense) to C$2.2M (income), Share in net loss of joint venture decrease from C$3K (expense) to C$0K.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 0.01 | 0.01 | 0.01 | 0 |
Gross Profit | ||||
Operating Income | -5.09 | -6.52 | -2.04 | -1.38 |
Net Income | -3.08 | -2.93 | -0.96 | -0.3 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 18.04 | 22.46 | 29.22 | 7.82 |
Total Liabilities | 13.37 | 14.98 | 19.6 | 16.62 |
Total Equity | 4.67 | 7.48 | 9.62 | -8.8 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -4.26 | -11.84 | -6.12 | -2.85 |
Cash From Investing Activities | -0 | 0.12 | -0 | |
Cash From Financing Activities | 0 | 32.13 | 31.6 | 8.74 |
Net Change in Cash | -4.27 | 20.41 | 25.48 | 5.89 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review